The expanding scope of the metabolic syndrome and implications for the management of cardiovascular risk in type 2 diabetes with particular focus on the emerging role of the thiazolidinediones

Author： Greenberg A.S.  

Publisher： Elsevier

ISSN： 1056-8727

Source： Journal of Diabetes and its Complications, Vol.17, Iss.4, 2003-07, pp. : 218-228

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Cardiovascular Disease Risk of Type 2 Diabetes Mellitus and Metabolic Syndrome: Focus on Aggressive Management of Dyslipidemia

By  

Current Diabetes Reviews, Vol. 1, Iss. 2, 2005-06 ,pp. : 127-135

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Thiazolidinediones in the Treatment of Patients with Type 2 Diabetes Mellitus

By Mooradian A.D.   Chehade J.   Thurman J.E.  

Treatments in Endocrinology, Vol. 1, Iss. 1, 2002-01 ,pp. : 13-20

Adis International

Access to resources Recommend Favorite

Management of Cardiovascular Risk Factors in Patients with Metabolic Syndrome

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 5, Iss. 3, 2007-07 ,pp. : 209-214

Bentham Science Publishers

Access to resources Recommend Favorite

The Metabolic Syndrome and Cardiovascular Risk

By  

Current Diabetes Reviews, Vol. 1, Iss. 2, 2005-06 ,pp. : 137-143

Bentham Science Publishers

Access to resources Recommend Favorite

Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS

By Teede H.   Hutchison S.   Zoungas S.   Meyer C.  

Endocrine Journal, Vol. 30, Iss. 1, 2006-08 ,pp. : 45-53

Humana Press, Inc

Access to resources Recommend Favorite